Prenatal lipopolysaccharide exposure programs the early-life lung development by modulating mesenchymal fibroblasts in a time- and dose-dependent manner
Prenatal LPS exposure induces heterogeneous structural and molecular changes in the newborn mice lung, showing LPS dose- and time-dependent modulation of mesenchymal fibroblast differentiation. These findings may contribute to refine the risk stratification of preterm infants exposed to prenatal infection/inflammation. Mesenchymal fibroblast plasticity and MYFs-LIFs phenotypic shifts may inspire preventive and therapeutic strategies for BPD.
Authors
- Marek Bartkuhn (ORCID: https://orcid.org/0000-0001-6872-9082)
- S. Bellusci
- Stefan Hadžić (ORCID: https://orcid.org/0000-0001-8459-2776)
- Harald Ehrhardt (ORCID: https://orcid.org/0000-0003-4587-1734)
- Annika Leidner
- Manuela Marega
- Tara Procida-Kowalski
- Ying Dong
- Stefano Rivetti
Institutions
- Justus-Liebig-Universität Gießen (DE)
- Quzhou City People's Hospital (CN)
- Helios Universitätsklinikum Wuppertal (DE)
- Quzhou University (CN)
- German Center for Lung Research (DE)
- Universities of Giessen and Marburg Lung Center (DE)
- Cardio-Pulmonary Institute (DE)
- University Hospital Ulm (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- BMC Medicine
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1186/s12916-025-04533-w
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00